Patient-Reported Vision Improves After Ocriplasmin for Vitreomacular Adhesion

Patients report meaningful improvements in vision after ocriplasmin treatment for vitreomacular adhesion (VMA), according to a pair of multicenter trials.
Reuters Health Information

Full Story →